FC9402 is a potent and selective sulfide quinone oxidoreductase (SQOR) inhibitor extracted from patent WO 2020/146636 A1. FC9402 attenuates TAC-induced cardiomyocyte pertrop and left ventricle (LV) fibrosis. FC9402 can be used for cardiovascular regulation[1].
FC9402 attenuates TAC-induced cardiomyocyte pertrop and left ventricle (LV) fibrosis[1].
[1]. WO 2020/146636 A1
















